Nilotinib as Coadjuvant Treatment with Doxorubicin in Patients with Sarcomas: A Phase I Trial of the Spanish Group for Research on Sarcoma

Overview of attention for article published in Clinical Cancer Research, November 2018

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Above-average Attention Score compared to outputs of the same age and source (51st percentile)

So far, Altmetric has seen 13 X posts from 10 X users, with an upper bound of 25,847 followers.

RT @bibliosalut: #PublicaSalutIB @idisbaib i Anatomia Patològica de @SonEspases participen en la fase I de l'Assaig del Grup Espanyol per a…

RT @bibliosalut: #PublicaSalutIB @idisbaib i Anatomia Patològica de @SonEspases participen en la fase I de l'Assaig del Grup Espanyol per a…

#PublicaSalutIB @idisbaib i Anatomia Patològica de @SonEspases participen en la fase I de l'Assaig del Grup Espanyol per a la Investigació del Sarcoma https://t.co/grEHX2sT7A https://t.co/nKZvGxopA6 https://t.co/AnbEDoPJnc

RT @infosalut: #PublicaSalutIB El @idisbaib y Anatomía Patológica de @SonEspases participan en la fase I del Ensayo del Grupo Español para…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.